Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Racial differences in therapies received by patients with cutaneous T cell lymphoma (CTCL): A single center retrospective cohort analysis.

View Full Paper
Ask AI
Bookmark
Share

Authors

KCKatherine CaseAMAngelo Alessandro MarraJSJeffrey M. Switchenko

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Case et al. (2024) studied this question.

synapsesocial.com/papers/68e66f03b6db6435875fa256https://doi.org/10.1200/jco.2024.42.16_suppl.e23141
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Persistent racial disparities in Sézary syndrome outcomes despite use of modern therapies: A single-center analysis2025
  2. 2Racial differences in survival and prognostic factors among patients with mycosis fungoides and Sézary syndrome: A systematic review and meta-analysis.2026
  3. 3Role of race in severity and survival of those with cutaneous T-cell lymphoma2025
  4. 4Abstract B160: Racial disparities in CAR T-cell therapy utilization and outcomes among patients with diffuse large B-cell lymphoma: A matched cohort study2025
  5. 5Abstract PS4-12-05: Real-world evidence of ethnic-racial disparities in tumor-infiltrating lymphocytes and survival outcomes in early-stage triple-negative breast cancer2026